Who makes salbutamol aqueous solution?

salbutamol aqueous solution is developed by University of Saskatchewan.

What development phase is salbutamol aqueous solution in?

salbutamol aqueous solution is FDA-approved (marketed).

Last reviewed 2026-04-20 · How we verify

salbutamol aqueous solution

University of Saskatchewan · FDA-approved active Small molecule Quality 2/100

At a glance

Generic name	salbutamol aqueous solution
Sponsor	University of Saskatchewan
Modality	Small molecule
Phase	FDA-approved

Approved indications

No approved indications tracked.

Common side effects

No common side effects on file.

Key clinical trials

Reversibility of Methacholine Induced Bronchoconstriction (PHASE4)
Nebulized Procaterol Versus Nebule Salbutamol for the Treatment of Moderate Acute Asthma (PHASE3)

Primary sources

Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.

Source	Used for
ClinicalTrials.gov	Trial enrolment, design, endpoints, results

Competitive intelligence

For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:

salbutamol aqueous solution CI brief — competitive landscape report
salbutamol aqueous solution updates RSS · CI watch RSS
University of Saskatchewan portfolio CI